Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Wanglong Deng

Wanglong Deng publishes mostly in Molecular Biology, Cancer Research and Oncology, on topics such as Cancer Genomics and Diagnostics, RNA modifications and cancer and Colorectal Cancer Treatments and Studies.

ORCID 0000-0003-4242-9166 OpenAlex
World rank
#1,347,205
of 7,710,434 ranked researchers
Rank in China
#198,127
of 978,568
Works
78
Citations
845
Citations per work
10.8
h-index
12
i10-index 17Top 65% in Molecular Biology
Wanglong Deng

What does Wanglong Deng research?

Wanglong Deng's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (36%).

Life Sciences: 28 works · 36.1% of their workBiochemistry, Genetics and Molecular Biology: 28 works · 36.1% of their workMolecular Biology: 16 works · 20.3% of their workCancer Research: 12 works · 15.8% of their workHealth Sciences: 28 works · 36.1% of their workMedicine: 28 works · 36.1% of their workOncology: 10 works · 13.0% of their workPulmonary and Respiratory Medicine: 7 works · 9.0% of their workSurgery: 6 works · 7.9% of their workPathology and Forensic Medicine: 5 works · 6.2% of their workEverything else: 22 works · 27.8% of their workTHEIR WORKWanglong Deng78works
Life Sciences36%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2836.1%
    1. Medicine2836.1%
  3. Everything else2227.8%
  1. 1Molecular Biology20% of their works
  2. 2Cancer Research16% of their works
  3. 3Oncology13% of their works
  4. 4Pulmonary and Respiratory Medicine9% of their works
  5. 5Surgery8% of their works
  6. 6Pathology and Forensic Medicine6% of their works

Research topics

Which keywords describe Wanglong Deng's research?

The keywords of their largest research topics: Cancer Genomics, Mutational Signatures, Cancer Progression, Cetuximab, KRAS Mutations, m6A-seq, RNA methylation and Biliary Tract Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer Genomics151 topic
  2. Mutational Signatures151 topic
  3. Cancer Progression122 topics
  4. Cetuximab71 topic
  5. KRAS Mutations71 topic
  6. RNA methylation71 topic
  7. m6A-seq71 topic
  8. Biliary Tract Cancer61 topic
  9. Cancer61 topic
  10. Cholangiocarcinoma61 topic
  11. Long Noncoding RNAs61 topic
  12. Immune Checkpoint Blockade51 topic
  13. Microsatellite Instability51 topic
  14. Molecular Characterization51 topic
  15. PD-1 and PD-L151 topic
  16. Pim Oncogenes51 topic
  17. Tumorigenesis51 topic

Where does Wanglong Deng work?

Wanglong Deng's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Wanglong Deng have?

OpenAlex counts 78 works and 845 citations for Wanglong Deng, an h-index of 12, ranking #1,347,205 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Wanglong Deng. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.